| 1 |
34931381 | Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention. | 2022 Mar |
2 |
| 2 |
33599853 | Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells. | 2021 Feb 18 |
5 |
| 3 |
34142331 | Pharmacological Activation of RXR-α Promotes Hematoma Absorption via a PPAR-γ-dependent Pathway After Intracerebral Hemorrhage. | 2021 Oct |
1 |
| 4 |
29642873 | Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway. | 2018 Apr 11 |
2 |
| 5 |
26451138 | Identification of Bexarotene as a PPARγ Antagonist with HDX. | 2015 |
4 |
| 6 |
22053058 | Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism. | 2012 Feb |
2 |
| 7 |
22223330 | A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers. | 2012 |
2 |
| 8 |
16495926 | A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours. | 2006 Mar 13 |
1 |
| 9 |
16729120 | The synthesis of tethered ligand dimers for PPARgamma-RXR protein heterodimers. | 2006 Jun 7 |
1 |